MOS vs MRKR · P/E 161, rev $11.12B vs $25.3M cap
The Mosaic Company (MOS) versus Marker Therapeutics Inc (MRKR) — a side-by-side from cached financials, not a winner call.
The Mosaic Company (MOS) is a agricultural inputs company listed on US.
Marker Therapeutics Inc (MRKR) is a biotechnology company listed on US.
Latest reported MOS revenue for 2024-12-31 was $11.12B. Net income was $202.0M. Revenue was down 18.8% from 2023-12-31 to 2024-12-31. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
MRKR does not have a complete income-statement cache yet.
MOS currently screens at market cap $7.15B and trailing P/E 160.8. MRKR currently screens at market cap $25.3M.
Not investment advice. Open the MOS and MRKR stock pages for the full models.
Not investment advice.